UCB
Frederic Leynen has extensive experience in insights and analytics within the pharmaceutical industry, currently serving as the Head of Insights-to-Impact and previously as the Head of R&D Insights & Analytics at UCB. Additionally, Frederic held the role of Senior Director for Lead Corporate Strategy & Business Development Insights at UCB. Other notable positions include Board Member at De Wroeter and Associate Partner at McKinsey & Company. Frederic also completed a Full-time MBA at INSEAD and served as a Manager in Enterprise Risk Services at Deloitte Belgium.
This person is not in the org chart
This person is not in any teams
UCB
46 followers
Ucb SA is a Belgium-based biopharmaceutical and specialty chemical company that specializes in two therapeutic areas: diseases of the central nervous system (CNS) and immunology.